TheJobsMapKaryopharm Therapeutics jobs and careers
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).
Founded in 2008 by Michael Christiano, Ronald A. DePinho and Sharon Shacham.
- Founded
- 2008
- Employees
- 251 to 500
- Total funding
- $546.7M
Leadership
The top of Karyopharm Therapeutics's org chart, with how many people report into each leader.
Richard Paulson
President & CEO
183 reports
Reshma Rangwala
Chief Medical Officer & Head of Research
46 reports
Sohanya Cheng
EVP, Chief Commercial Officer & Head of Business Development
24 reports
Stephen Li
Senior Vice President, Regulatory Affairs
20 reports
Lori Macomber
EVP, CFO & Treasurer
19 reports
Andrew Lancaster
Vp, Information Technology
19 reports
Stuart Poulton
Executive Vice President, Chief Development Officer
14 reports
Emily Ziedman
Senior Director
9 reports
Lisa DiPaolo
Chief Human Resources Officer
8 reports
Board
Zhen Su
Director
Garen Bohlin
Director
Chen Schor
Board Member
Christy J. Oliger
Director
Mansoor Raza Mirza
Director
Deepa R. Pakianathan
Director